Seeking Alpha

NPS Pharmaceuticals (NPSP +5.4%) clocks a gain a day after announcing it completed its...

NPS Pharmaceuticals (NPSP +5.4%) clocks a gain a day after announcing it completed its submission to the FDA for its experimental Gattex drug - a hopeful sign which follows the firm reporting "adverse events" in October with trials.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector